Trade Summary

2 days ago, Kurzweil Ray, serving as Dir at United Therapeutics Corp (UTHR), sold 4,910 shares at $489.02 per share, for a total transaction value of $2,401,088.00. Following this transaction, Kurzweil Ray now holds 12,670 shares of UTHR.

This sale represents a 28.00% decrease in Kurzweil Ray's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, March 4, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 5, 2026, 1 day after the trade was made.

United Therapeutics Corp operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.